{"id":"https://openalex.org/A5034235684","orcid":"https://orcid.org/0000-0003-4132-5971","observed_orcids":["https://orcid.org/0000-0003-4132-5971"],"display_name":"P. E. Kargopolova","raw_author_names":["P. E. Kargopolova","Pauline E. Kargopolova","\u041a\u0430\u0440\u0433\u043e\u043f\u043e\u043b\u043e\u0432\u0430 \u041f.\u0415."],"full_name":"Pauline E. Kargopolova","works_count":4,"cited_by_count":2,"summary_stats":{"2yr_mean_citedness":1.0,"h_index":1,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5034235684","orcid":"https://orcid.org/0000-0003-4132-5971","observed_orcids":["https://orcid.org/0000-0003-4132-5971"]},"affiliations":[{"institution":{"id":"https://openalex.org/I4405272539","ror":"https://ror.org/04anvdv29","display_name":"Generium Pharmaceuticals (Russia)","country_code":"RU","type":"company","lineage":["https://openalex.org/I4405272539"]},"years":[2024,2023,2022]}],"last_known_institutions":[{"id":"https://openalex.org/I4405272539","ror":"https://ror.org/04anvdv29","display_name":"Generium Pharmaceuticals (Russia)","country_code":"RU","type":"company","lineage":["https://openalex.org/I4405272539"]}],"topics":[{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","count":2,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","count":2,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","count":2,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","count":1,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","count":1,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"topic_share":[{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","value":2.35e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14108","display_name":"Medical and Pharmaceutic Studies","value":1.53e-05,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11754","display_name":"SARS-CoV-2 detection and testing","value":1.18e-05,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13410","display_name":"Immune responses and vaccinations","value":8.5e-06,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","value":6e-06,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","score":0.7069171071052551},{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.6969081163406372},{"id":"159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","score":0.6422843933105469},{"id":"147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","score":0.5837600827217102},{"id":"126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","score":0.13879293203353882}],"counts_by_year":[{"year":2022,"works_count":1,"oa_works_count":1,"cited_by_count":0},{"year":2023,"works_count":1,"oa_works_count":1,"cited_by_count":0},{"year":2024,"works_count":1,"oa_works_count":1,"cited_by_count":1},{"year":2026,"works_count":0,"oa_works_count":0,"cited_by_count":1}],"display_name_alternatives":["P. E. Kargopolova","Pauline E. Kargopolova","\u041a\u0430\u0440\u0433\u043e\u043f\u043e\u043b\u043e\u0432\u0430 \u041f.\u0415."],"block_key":"p kargopolova","works_api_url":"https://api.openalex.org/works?filter=author.id:A5034235684","awards_count":0,"updated_date":"2026-11-04T11:47:51","created_date":"2022-09-12T00:00:00"}